Get Started

IMCR

NASD Immunocore Holdings Plc Shs Sponsored American Depositary Shares Repr 1 Sh
Nov 3, 2026 · 1:12 PM ET DELAYED Market Open

$30.15 ↑ +0.36 (+1.21%) Trading Up from the previous close of $29.79, $0.80 below the day’s high of $30.95

YTD change
-13.14%
vs 20-day SMA
-0.59%
vs 200-day SMA
-5.04%

Price ranges

Previous day
$29.64 $30.83
open $30.56 close $29.79
-$0.77 (-2.52%)
Today
$29.83 $30.95
open $29.83 now $30.15
+$0.32 (+1.07%)
Past week
$29.64 $32.72
from $31.28 now $30.15
-$1.13 (-3.61%)
Past month
$27.50 $33.57
from $29.59 now $30.15
+$0.56 (+1.89%)
This year
$27.50 $37.95
from $34.71 now $30.15
-$4.56 (-13.14%)

Price & Performance

+1.27 (+4.45%) / 6M

$27.01$30.79$34.57$38.35May 4Aug 4Nov 2

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 60.8% away from all-time highs of $76.98
  • IMCR is down 13% since the beginning of the year
  • IMCR is down 7% over the past 12 months
  • IMCR is up 2% over the past 1 month
  • 16% of all IMCR investors are betting against IMCR

IMCR reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -8.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.02
Earnings momentum +84.7% Quarterly EPS growth
Quarterly change +84.7%

Valuation

P/E ratio N/A
Enterprise value $1.1B
Beta 0.74

Balance sheet & scale

IncomeN/A
Revenue$430.0M
Cash$880.2M
Debt$435.0K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $1.6B

Immunocore Holdings Plc operates as a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal TCRs Against X disease. the firm's lead product KIMMTRAK is a TCR therapeutic for the treatment of patients with unresectable or metastatic uveal melanoma, in the United States, European Union, Canada, Australia and the United Kingdom. Its pipeline products include IMC-F106C, IMC-F115C, IMC-F119C, IMC-F117C, IMC-F113V, IMC-I109V, IMC-SII8AI, among others. The company was founded on January 7, 2021 and is headquartered in Abingdon, the United Kingdom.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,410.99 -0.46%
JNJ Johnson & Johnson $270.56 -0.97%
ABBV AbbVie, Inc. $288.84 -2.05%
MRK Merck & Co., Inc. $148.36 -0.78%
RHHBY Roche Holding Ltd Sponsored ADR $60.67 -0.98%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.